Literature DB >> 20571836

Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies.

Klaus G Petry1, Bruno Brochet, Vincent Dousset, Jean Rodolphe Vignes, Claudine Boiziau.   

Abstract

Multiple sclerosis (MS) is described as originating from incompletely explained neuroinflammatory processes, dysfunction of neuronal repair mechanisms and chronicity of inflammation events. Blood-borne immune cell infiltration and microglia activation are causing both neuronal destruction and myelin loss, which are responsible for progressive motor deficiencies, organic and cognitive dysfunctions. MRI as a non-invasive imaging method offers various ways to visualise de- and remyelination, neuronal loss, leukocyte infiltration, blood-brain barrier modification and new sensors are emerging to detect inflammatory lesions at an early stage. We describe studies performed on experimental autoimmune encephalomyelitis (EAE) animal models of MS that shed new light on mechanisms of functional impairments to understand the neurological handicap in MS. We focus on examples of neuroinflammation-mediated inhibition of CNS repair involving adult neurogenesis in the sub-ventricular zone and hippocampus and such experimentally observed inhibitions could reflect deficient plasticity and activation of compensatory mechanisms in MS. In parallel with cognitive decline, organic deficits such as bladder dysfunction are described in most of MS patients. Neuropharmacological interventions, electrical stimulation of nerves, MRI and histopathology follow-up studies helped in understanding the operating events to remodel the neurological networks and to compensate the inflammatory lesions both in spinal cord and in cortical regions. At the molecular level, the local production of reactive products is a well-described phenomenon: oxidative species disturb cellular physiology and generate new molecular epitopes that could further promote immune reactions. The translational research from EAE animal models to MS patient cohorts helps in understanding the mechanisms of the neurological handicap and in development of new therapeutic concepts in MS.

Entities:  

Mesh:

Year:  2010        PMID: 20571836     DOI: 10.1007/s00702-010-0432-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  112 in total

1.  MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE.

Authors:  M Rausch; P Hiestand; D Baumann; C Cannet; M Rudin
Journal:  Magn Reson Med       Date:  2003-08       Impact factor: 4.668

2.  Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.

Authors:  Martin Bendszus; Gesa Ladewig; Leonie Jestaedt; Bernd Misselwitz; Laszlo Solymosi; Klaus Toyka; Guido Stoll
Journal:  Brain       Date:  2008-07-24       Impact factor: 13.501

Review 3.  Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.

Authors:  Rocio S Lopez-Diego; Howard L Weiner
Journal:  Nat Rev Drug Discov       Date:  2008-11       Impact factor: 84.694

4.  In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance.

Authors:  V Dousset; C Delalande; L Ballarino; B Quesson; D Seilhan; M Coussemacq; E Thiaudiére; B Brochet; P Canioni; J M Caillé
Journal:  Magn Reson Med       Date:  1999-02       Impact factor: 4.668

5.  Evidence for the production of peroxynitrite in inflammatory CNS demyelination.

Authors:  A H Cross; P T Manning; M K Stern; T P Misko
Journal:  J Neuroimmunol       Date:  1997-12       Impact factor: 3.478

6.  Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis.

Authors:  Laura Calza; Mercedes Fernandez; Alessandro Giuliani; Luigi Aloe; Luciana Giardino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.

Authors:  Marina O Ziehn; Andrea A Avedisian; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2010-02-15       Impact factor: 5.662

8.  Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors.

Authors:  Heather C Wilson; Claus Onischke; Cedric S Raine
Journal:  Glia       Date:  2003-11       Impact factor: 7.452

9.  Macrophages in multiple sclerosis.

Authors:  W Brück; N Sommermeier; M Bergmann; U Zettl; H H Goebel; H A Kretzschmar; H Lassmann
Journal:  Immunobiology       Date:  1996-10       Impact factor: 3.144

10.  Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging.

Authors:  Laura-Adela Harsan; Jérôme Steibel; Anita Zaremba; Arnaud Agin; Rémy Sapin; Patrick Poulet; Blandine Guignard; Nathalie Parizel; Daniel Grucker; Nelly Boehm; Robert H Miller; M Said Ghandour
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

View more
  3 in total

Review 1.  Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.

Authors:  Mao Zhang; Ziyi Ma; Haochen Qin; Zhongxiang Yao
Journal:  Mol Neurobiol       Date:  2015-08-05       Impact factor: 5.590

2.  Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord.

Authors:  Karolina Kucharova; Yunchao Chang; Andrej Boor; Voon Wee Yong; William B Stallcup
Journal:  J Neuroinflammation       Date:  2011-11-13       Impact factor: 8.322

3.  NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair.

Authors:  Karolina Kucharova; William B Stallcup
Journal:  J Neuroinflammation       Date:  2015-09-04       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.